News + Filings Transactions Holdings
|
Alaska Permanent Fund Corp
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 2.6M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 467.1k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 747.3k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 191.7k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 191.7k | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Purchase | Common Stock | 235k | $15.00 | $3.5M | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series A redeemable convertible preferred stock | 20.4M | $0.00 | $0 | See Footnotes | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series B redeemable convertible preferred stock | 3.3M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series B redeemable convertible preferred stock | 5.3M | $0.00 | $0 | See Footnotes | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series C redeemable convertible preferred stock | 1.3M | $0.00 | $0 | See Footnote | 10/16/2020 |
| 10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series C redeemable convertible preferred stock | 1.3M | $0.00 | $0 | See Footnotes | 10/16/2020 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Series B convertible preferred stock | 55.6k | $0.00 | $0 | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Series A-1 convertible preferred stock | 666.7k | $0.00 | $0 | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Series A-1 convertible preferred stock | 2.2M | $0.00 | $0 | By Yukon Investors, LLC | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Purchase | Common Stock | 1.5M | $20.00 | $30M | | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Common Stock | 55.6k | $0.00 | $0 | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Yukon Investors, LLC | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Common Stock | 666.7k | $0.00 | $0 | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P | 10/16/2019 |
| 10/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Common Stock | 2.2M | $0.00 | $0 | By Yukon Investors, LLC | 10/16/2019 |
| 01/16/2019 | Vir Biotechnology, Inc. | VIR | Conversion | Series B convertible preferred stock | 1.1M | $0.00 | $0 | By Yukon Investors, LLC | 10/16/2019 |
| 08/06/2013 | American Homes 4 Rent | AMH | Purchase | Class A Common Shares | 1.6M | $16.00 | $25M | | 07/31/2013 |
|